Imagine using hydrogen as a clean battery to power the tiny biological machines that make chemicals. Instead of using expensive or polluting additives to keep these machines running, this project uses hydrogen to drive the process. It's like swapping a dirty diesel engine for a clean electric one in a chemical factory.
Industrial biotechnology currently relies on fossil-sourced or carbon-rich reactants and expensive cofactor recycling. This leads to high production costs, significant resource waste, and complex downstream processing.
A set of robust, scalable hydrogenase catalysts and specific alcohol dehydrogenases for producing Tulipalin A at the gram scale.
If you are a fine chemical manufacturer dealing with high production costs due to sacrificial reagents — this project developed robust hydrogenases that use H2 as a clean reactant. This reduces the need for carbon-rich additives and simplifies the cleaning process after production.
If you are a bio-based material producer dealing with inefficient cofactor recycling — this project developed a scalable H2-driven biotechnology. This allows for the production of specialty chemicals like Tulipalin A at the gram scale with minimal resource loss.
If you are a commodity chemical plant dealing with high energy usage and fossil-fuel dependence — this project developed catalysts that enable the decarbonization of industrial biotechnology. This makes the production of chemicals more economically competitive against fossil-sourced reactants.
Based on available project data, it reduces costs by eliminating the need for excess sacrificial reagents and minimizing downstream processing due to high catalyst selectivity.
Yes, the project aims to demonstrate these hydrogenases in an industrial environment reaching TRL6, ensuring they are scalable and compatible with existing infrastructure.
Based on available project data, no specific licensing terms are mentioned, but the project involves 7 industrial partners, including 7 SMEs, suggesting a strong commercial focus.
The technology is designed to be compatible with existing industrial biotechnology infrastructure to facilitate a rapid transition to renewable resources.
The project runs from 2024-01-01 to 2027-12-31, aiming to reach TRL6 by the end of the period.
The consortium is heavily weighted toward commercial application, with an industry ratio of 64%. Out of 11 partners, 7 are SMEs and 7 are industrial entities, indicating that the research is being driven by market needs rather than purely academic curiosity. The collaboration spans 7 countries, providing a broad European base for industrial validation.
Contact the Technical University of Munich (TUM) regarding the CirculH2 project.
Contact us to connect with the CirculH2 consortium for pilot integration.
